Actavis filed for FDA approval of its 10-mg, 20-mg, 30-mg and 40-mg isotretinoin capsules. The drug is a generic copy of Ranbaxy's acne drug Absorica, which is indicated for patients 12 and older with severe, recalcitrant nodular acne. The filing prompted Ranbaxy, Cipher Pharmaceuticals and Galephar Pharmaceutical Research to sue Activis in federal court.

Full Story:
Drug Store News

Related Summaries